Background: Lactational breast abscess is attributed to higher morbidities among women, specifically from developing countries. Though many treatment options are available, still consensus regarding the modality yielding the best outcome is scarce. The study's objective was to compare the outcome of lactational breast abscess following incision & drainage (ID) versus ultrasound-guided needle aspiration (USGNA). Methodology: This prospective comparative investigation was carried upon a sample of 59 female patients with lactational breast abscess (chosen via non-probability, consecutive sampling), presenting to the Department of Surgery at Liaquat University Hospital, Hyderabad. The patients were divided into two groups, namely Group A (ID) and Group B (USGNA). Data was documented using a structured questionnaire, including inquiries related to sociodemographic details, disease specifics, and treatment outcomes (mainly abscess resolution, uninterrupted breastfeeding and fistula formation). Results: The results showed that 3 patients (5.08%) from group A developed mammary fistula, 26 (44.06%) with complete resolution, and only 1 (1.69%) patient attained uninterrupted breastfeeding. In group B, there was full resolution in 28 (47.45%) patients, and the abscess of 2 (3.38%) patients did not completely resolve, while 28 (47.45%) attained uninterrupted breastfeeding. Conclusion: It can be concluded that USGNA yields a better outcome in the treatment of lactational breast abscess in terms of lesser incidence of fistula development, the better probability of complete resolution and a significantly higher rate of attainments of the ability to breastfeed uninterruptedly.
Though the life has been totally changed after the covid-19 pandemic and one has never imagined being in such circumstances. The face mask was once thought to be the beauty for operating surgeons is now globally indicated to be prevented from the covid-19 infection. Every aspect of life has been affected by the pandemic including the routine hospital services for the elective cases.1As the evolution is the part of life so we all are growing to make our life adjustable with it. No doubt the prevention and protection is the key to survive but along with that one should have courage to fight with it. Hence it is an unpleasant and life threatening disease and also very distressing for the one who became its victim.2 Globally the covid-19 pandemic has an alarming effects on the precious lives and its causing huge challenges to the everyday routine3. By the April 2020, globally more than 8 lac cases of covid-19 has recorded. As the cancer patients are already immune compromised and more prone to get contacted with covid-19 infection, as is supported by a Chinese study that they are more vulnerable to develop complications as well4,5. When a cancer patient simultaneously contacted by the covid-19 infection then the treatment should be prioritize that which patient can be delayed until the control over active infection can occur. Though the risk of transmission to the health care workers (HCW) is significant while treating such patients.6As there should be a balanced practice for the management of covid-19 pandemic and for the cancer patients and being HCW we need to cover both the diseases at the same time to save the precious lives. There are international guidelines to manage the cancer patients during covid-19 pandemic but the decision is still vary from patient to patient according to the stage of the cancer and also the severity of covid-19 infection. It has been observed that multi-disciplinary approach plays the major role for the cancer patient management including surgeons along with the oncologist, radiologist, pathologist, psychiatrist, councilor and nurse. Meanwhile they all are facing the major risk of being contacted to the covid-19 when their patients are being the victim of it7.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.